Inhibition of Thioredoxin Reductase by Targeted Selenopolymeric Nanocarriers Synergizes the Therapeutic Efficacy of Doxorubicin in MCF7 Human Breast Cancer Cells. uri icon

authors

  • Purohit, Mahaveer P
  • Verma, Neeraj K
  • Kar, Aditya K
  • Amrita Singh MD
  • Ghosh, Debabrata
  • Patnaik, Satyakam

publication date

  • October 10, 2017